VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $568,000 | -23.8% | 3,186 | -5.0% | 0.16% | -16.8% |
| Q2 2015 | $745,000 | -40.4% | 3,353 | -46.7% | 0.19% | -39.6% |
| Q1 2015 | $1,249,000 | +39.2% | 6,292 | +0.4% | 0.32% | +36.8% |
| Q4 2014 | $897,000 | +9.0% | 6,270 | 0.0% | 0.23% | +4.1% |
| Q3 2014 | $823,000 | +4.0% | 6,270 | 0.0% | 0.22% | +29.1% |
| Q2 2014 | $791,000 | -4.4% | 6,270 | 0.0% | 0.17% | -9.5% |
| Q1 2014 | $827,000 | -20.4% | 6,270 | -29.2% | 0.19% | -32.6% |
| Q4 2013 | $1,039,000 | +12.6% | 8,850 | 0.0% | 0.28% | +2.5% |
| Q3 2013 | $923,000 | +14.9% | 8,850 | -5.1% | 0.28% | +3.4% |
| Q2 2013 | $803,000 | – | 9,330 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |